Ignite Creation Date:
2024-05-06 @ 7:04 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05881408
Status:
RECRUITING
Last Update Posted:
2024-05-10
First Post:
2023-05-19
Brief Title:
A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec SRP-9001 in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy DMD
Sponsor:
Sarepta Therapeutics Inc
Organization:
Sarepta Therapeutics Inc
Organization Data
Organization:
Sarepta Therapeutics Inc
Class:
INDUSTRY
Study ID:
SRP-9001-303
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sarepta Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Hoffmann-La Roche | INDUSTRY |